The influence of long-term CPAP therapy on metabolic variables in obstructive sleep apnea patients

W. Kuczynski (Lodz, Poland), A. Stolarz (Lodz, Poland), P. Bialasiewicz (Lodz, Poland)

Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing
Session: Cardiovascular and metabolic consequences of sleep-disordered breathing
Session type: Thematic Poster
Number: 4334
Disease area: Sleep and breathing disorders

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
W. Kuczynski (Lodz, Poland), A. Stolarz (Lodz, Poland), P. Bialasiewicz (Lodz, Poland). The influence of long-term CPAP therapy on metabolic variables in obstructive sleep apnea patients. 4334

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cardiovascular regulation effects of CPAP therapy in obstructive sleep apnea patients with and without hypertension during daytime
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II
Year: 2012


Long-term cardiovascular outcomes of patients with obstructive sleep apnoea not treated with nasal CPAP
Source: Eur Respir J 2002; 20: Suppl. 38, 294s
Year: 2002

Telecoaching to improve physical activity in patients with obstructive sleep apnea treated with CPAP
Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Year: 2020


Effects of CPAP treatment on physical fitness in patients with obstructive sleep apnoea syndrome (OSAS)
Source: Eur Respir J 2003; 22: Suppl. 45, 97s
Year: 2003

Reported but not measured sleep latency predicts successful CPAP therapy in patients with obstructive sleep apnoea
Source: Eur Respir J 2002; 20: Suppl. 38, 101s
Year: 2002

Long-term CPAP compliance in women with obstructive sleep apnoea
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012


Cardiovascular and metabolic effects of CPAP in obese obstructive sleep apnoea patients
Source: Eur Respir J 2008; 31: 223-225
Year: 2008


Impact of antihypertensive drugs on Watch-PAT variables in patients with obstructive sleep apnea.
Source: International Congress 2019 – Diagnostic issues in obstructive sleep apnoea
Year: 2019

Effects of nCPAP treatment on quality of life of patients with obstructive sleep apnoea syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 410s
Year: 2006

AutoCPAP devices accurately identify obstructive sleep apnea patients with residual apnea during treatment
Source: Annual Congress 2011 - Obstructive sleep apnoea : physiology, diagnostic tools and technology
Year: 2011


The effect of CPAP treatment on Galectin-3 level in patients with severe obstructive sleep apnea
Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing
Year: 2018


Effects of a lifestyle intervention in obese obstructive sleep apnoea patients treated with CPAP
Source: Annual Congress 2012 - Sleep apnoea: clinical topics
Year: 2012


Role of CPAP treatment in elderly with moderate obstructive sleep apnea
Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects
Year: 2019


CPAP treatment for obstructive sleep apnoea syndrome after CPAP training term
Source: Eur Respir J 2002; 20: Suppl. 38, 102s
Year: 2002

Determinants of CPAP compliance in bariatric patients with obstructive sleep apnoea
Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment
Year: 2017

Effect of continuous positive airway pressure therapy on metabolic control in patients with morbid obesity and obstructive sleep apnoea
Source: Annual Congress 2013 –Burn after reading: inflammation in sleep disordered breathing
Year: 2013


Is the daily duration of nasal CPAP ventilation the main determinant of improvement of blood gases in OSAS (obstructive sleep apnoea syndrome) patients?
Source: Eur Respir J 2001; 18: Suppl. 33, 390s
Year: 2001

Efficacy of continuous positive airway pressure in treatment of patients with bradyarrhythmias associated with obstructive sleep apnoea syndrome
Source: Annual Congress 2006 - Cardiovascular consequences of obstructive sleep apnoea
Year: 2006

Long-term outcome of nCPAP therapy in sleep apnoea patients
Source: Eur Respir J 2004; 24: Suppl. 48, 569s
Year: 2004

Daytime hypoxemia in obstructive sleep apnoea (OSA) subjects before CPAP therapy
Source: Annual Congress 2009 - Clinical aspects of sleep apnoea
Year: 2009